Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Feb;29(2):333–339. doi: 10.1128/jcm.29.2.333-339.1991

Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment.

J R Hamilton 1, A Noble 1, D W Denning 1, D A Stevens 1
PMCID: PMC269763  PMID: 2007642

Abstract

Cryptococcal antigen titers in 97 serum and 42 cerebrospinal fluid (CSF) specimens from 37 AIDS patients with culture-proven cryptococcal infection were determined with the Meridian kit (Meridian Diagnostics Inc., Cincinnati, Ohio) before and after treatment with pronase. The geometric mean titers before and after pronase treatment were 1:45 and 1:588 in serum and 1:97 and 1:79 in CSF, respectively. Only on serum (but not CSF) specimens after pronase treatment were (i) titers increased by 2 to 13 dilutions on 57% of the specimens, all of which had titers of less than or equal to 1:128 before pronase treatment, (ii) false-negative reactions on 27% of specimens before pronase treatment eliminated, all of which had titers from 1:4 to 1:4,096, (iii) prozone-like reactions (titer, less than or equal to 1:256) on 9% of the specimens before pronase treatment eliminated, and (iv) agglutination reactions on all specimens stronger and easier to interpret. Antifungal agents added to serum as well as freeze-thaw cycles did not change antigen titers in serum. After two separate tests, the same titers were obtained on 94% of 35 serum specimens that were treated with pronase and on 96% of 53 CSF specimens that were not treated with pronase. A total of 26 serum specimens and 28 CSF specimens from patients with no cryptococcal disease were negative before and after pronase treatment. The IBL kit (International Biological Labs Inc., Cranbury, N.J.) was compared with the Meridian kit on 41 serum specimens and 14 CSF specimens. Results from the two kits agreed on 54 and 68% of serum specimens and 86 and 93% of CSF specimens before and after pronase treatment, respectively. The IBL kit generally produced higher titers on specimens in disagreement and produced no prozone-like reactions. Routine pronase treatment of serum is recommended with the Meridian kit in order to eliminate false-negative and unclear agglutination reactions by producing a consistent interpretation of agglutination reactions. CSF specimens do not require pronase treatment. Titer results produced by the kits from the two different manufacturers varied considerably: the kits should not be used interchangeably for determining antigen titers in serum specimens.

Full text

PDF
333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Denning D. W., Tucker R. M., Hanson L. H., Hamilton J. R., Stevens D. A. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med. 1989 Oct;149(10):2301–2308. [PubMed] [Google Scholar]
  2. Diamond R. D., Bennett J. E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974 Feb;80(2):176–181. doi: 10.7326/0003-4819-80-2-176. [DOI] [PubMed] [Google Scholar]
  3. Eng R. H., Bishburg E., Smith S. M., Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med. 1986 Jul;81(1):19–23. doi: 10.1016/0002-9343(86)90176-2. [DOI] [PubMed] [Google Scholar]
  4. Eng R. H., Person A. Serum cryptococcal antigen determination in the presence of rheumatoid factor. J Clin Microbiol. 1981 Dec;14(6):700–702. doi: 10.1128/jcm.14.6.700-702.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fisher B. D., Armstrong D. Cryptococcal interstitial pneumonia: value of antigen determination. N Engl J Med. 1977 Dec 29;297(26):1440–1441. doi: 10.1056/NEJM197712292972606. [DOI] [PubMed] [Google Scholar]
  6. Goodman J. S., Kaufman L., Koenig M. G. Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen. N Engl J Med. 1971 Aug 19;285(8):434–436. doi: 10.1056/NEJM197108192850804. [DOI] [PubMed] [Google Scholar]
  7. Gordon M. A., Lapa E. W. Elimination of rheumatoid factor in the latex test for cryptococcosis. Am J Clin Pathol. 1974 Apr;61(4):488–494. doi: 10.1093/ajcp/61.4.488. [DOI] [PubMed] [Google Scholar]
  8. Gray L. D., Roberts G. D. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J Clin Microbiol. 1988 Nov;26(11):2450–2451. doi: 10.1128/jcm.26.11.2450-2451.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hay R. J., Mackenzie D. W. False positive latex tests for cryptococcal antigen in cerebrospinal fluid. J Clin Pathol. 1982 Feb;35(2):244–245. doi: 10.1136/jcp.35.2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Prevost E., Newell R. Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital. J Clin Microbiol. 1978 Nov;8(5):529–533. doi: 10.1128/jcm.8.5.529-533.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Snow R. M., Dismukes W. E. Cryptococcal meningitis: diagnostic value of cryptococcal antigen in cerebrospinal fluid. Arch Intern Med. 1975 Sep;135(9):1155–1157. doi: 10.1001/archinte.135.9.1155. [DOI] [PubMed] [Google Scholar]
  12. Stamm A. M., Polt S. S. False-negative cryptococcal antigen test. JAMA. 1980 Sep 19;244(12):1359–1359. [PubMed] [Google Scholar]
  13. Stockman L., Roberts G. D. Corrected version specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors. J Clin Microbiol. 1983 May;17(5):945–947. doi: 10.1128/jcm.17.5.945-947.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wu T. C., Koo S. Y. Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen. J Clin Microbiol. 1983 Nov;18(5):1127–1130. doi: 10.1128/jcm.18.5.1127-1130.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES